SOPH
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
SOPHiA GENETICS SA (SOPH) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.
Quantitative Factor Evaluation • Updated
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | B- (3.0) | B- (2.9) | B- (3.0) | A- (3.9) | C+ (2.6) | B- (3.1) |
| 2026-11-08 | B- (3.0) | B- (2.9) | B- (3.0) | B+ (3.5) | C+ (2.6) | B- (3.0) |
| 2026-11-01 | B- (3.0) | B- (2.9) | B (3.2) | A (4.4) | C+ (2.7) | B (3.2) |
| 2026-10-25 | B- (3.0) | B- (2.9) | B (3.2) | A (4.3) | C+ (2.6) | B (3.2) |
Showing the last month only. Subscribe for the full factor score history.
For more — Subscribe